Copy Number Alterations in Enzyme-Coding and Cancer-Causing Genes Reprogram Tumor Metabolism
Reads0
Chats0
TLDR
This study has shown that metabolic and cancer-causing genes are unexpectedly often proximally positioned in the chromosome and share loci with coaltered copy numbers across multiple cancers, and identified 119 new metabolic cancer genes likely to be involved in rewiring cancer cell metabolism.Abstract:
Somatic copy number alterations frequently occur in the cancer genome affecting not only oncogenic or tumor suppressive genes, but also passenger and potential co-driver genes. An intrinsic feature resulting from such genomic perturbations is the deregulation in the metabolism of tumor cells. In this study, we have shown that metabolic and cancer causing genes are unexpectedly often proximally positioned in the chromosome and share loci with co-altered copy numbers across multiple cancers (19 cancer types from The Cancer Genome Atlas). We have developed an analysis pipeline - Identification of Metabolic Cancer Genes (iMetCG), to infer the functional impact on metabolic remodeling from such co-amplifications and co-deletions and delineate genes driving cancer metabolism from those that are neutral. Using our identified metabolic genes we were able to classify tumors based on their tissue and developmental origins. These metabolic genes were similar to known cancer genes in terms of their network connectivity, isoform frequency and evolutionary features. We further validated these identified metabolic genes by (i) using gene essentiality data from several tumor cell-lines, (ii) showing that these identified metabolic genes are strong indicators for patient survival, and (iii) observing a significant overlap between our identified metabolic genes and known cancer metabolic genes. Our analyses revealed a hitherto unknown generic mechanism for large-scale metabolic reprogramming in cancer cells based on linear gene proximities between cancer causing and metabolic genes. We have identified 119 new metabolic cancer genes likely to be involved in rewiring cancer cell metabolism.read more
Citations
More filters
Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells
Matthew G. Vander Heiden,Matthew G. Vander Heiden,Jason W. Locasale,Jason W. Locasale,Kenneth D. Swanson,Hadar Sharfi,Gregory J. Heffron,Daniel Amador-Noguez,Heather R. Christofk,Gerhard Wagner,Joshua D. Rabinowitz,John M. Asara,Lewis C. Cantley,Lewis C. Cantley +13 more
TL;DR: In this paper, the authors demonstrate that phosphoenolpyruvate (PEP) can act as a phosphate donor in mammalian cells because PEP participates in the phosphorylation of the glycolytic enzyme phosphoglycerate mutase (PGAM1) in PKM2-expressing cells.
Journal ArticleDOI
Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival.
Edoardo Gaude,Christian Frezza +1 more
TL;DR: It is found that cancers undergo a tissue-specific metabolic rewiring, which converges towards a common metabolic landscape, and suppression of mitochondrial genes is identified as a key metabolic signature of metastatic melanoma and renal cancer, and metastatic cell lines.
Journal ArticleDOI
Genetic etiology of oral cancer
TL;DR: This review examines, in detail, the mechanisms of genetic alteration which are considered to be responsible for the initiation of oral cancer.
Journal ArticleDOI
DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas
Anat Ben-Shlomo,Nan Deng,Evelyn Ding,Masaaki Yamamoto,Adam N. Mamelak,Vera Chesnokova,Artak Labadzhyan,Shlomo Melmed +7 more
TL;DR: It is concluded that cAMP, which induces somatotroph proliferation and GH secretion, may concomitantly induce DNA damage, potentially linking hormone hypersecretion to SCNA and genome instability.
Journal ArticleDOI
A Conceptual Framework for Studying and Investing in Precision Nutrition
TL;DR: This review discusses a number of sources of metabolic heterogeneity and presents some of the research investments that will be needed to make applications of precision nutrition practical.
References
More filters
Journal ArticleDOI
Hallmarks of cancer: the next generation.
TL;DR: Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.
Journal ArticleDOI
Cancer Genome Landscapes
Bert Vogelstein,Nickolas Papadopoulos,Victor E. Velculescu,Shibin Zhou,Luis A. Diaz,Kenneth W. Kinzler +5 more
TL;DR: This work has revealed the genomic landscapes of common forms of human cancer, which consists of a small number of “mountains” (genes altered in a high percentage of tumors) and a much larger number of "hills" (Genes altered infrequently).
Journal ArticleDOI
Lethality and centrality in protein networks
TL;DR: It is demonstrated that the phenotypic consequence of a single gene deletion in the yeast Saccharomyces cerevisiae is affected to a large extent by the topological position of its protein product in the complex hierarchical web of molecular interactions.
Journal ArticleDOI
Tumor Cell Metabolism: Cancer's Achilles' Heel
TL;DR: The peculiarities of tumor cell metabolism are reviewed to discuss the alterations in signal transduction pathways and/or enzymatic machineries that account for metabolic reprogramming of transformed cells.
Journal ArticleDOI
Pan-cancer patterns of somatic copy number alteration
Travis I. Zack,Travis I. Zack,Steven E. Schumacher,Steven E. Schumacher,Scott L. Carter,Andrew D. Cherniack,Gordon Saksena,Barbara Tabak,Michael S. Lawrence,Cheng-Zhong Zhang,Jeremiah Wala,Craig H. Mermel,Carrie Sougnez,Stacey Gabriel,Bryan Hernandez,Hui Shen,Peter W. Laird,Gad Getz,Matthew Meyerson,Rameen Beroukhim +19 more
TL;DR: The Cancer Genome Atlas Pan-Cancer data set was used in this article to investigate the role of SCNAs in cancer-related SCNA patterns, including whole-genome doubling, TP53 mutations, CCNE1 amplifications and alterations of PPP2R complex.
Related Papers (5)
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures
Nicholas A. Graham,Nicholas A. Graham,Aspram Minasyan,Anastasia Lomova,Ashley A. Cass,Nikolas G. Balanis,Michael C. Friedman,Shawna Chan,Sophie Zhao,Adrian Delgado,James Go,Lillie Beck,Christian Hurtz,Carina Ng,Rong Qiao,Johanna ten Hoeve,Nicolaos Palaskas,Hong Wu,Hong Wu,Markus Müschen,Markus Müschen,Asha S. Multani,Elisa Port,Steven M. Larson,Nikolaus Schultz,Daniel Braas,Heather R. Christofk,Ingo K. Mellinghoff,Thomas G. Graeber +28 more
Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types.
Cheng Wang,Yayun Gu,Kai Zhang,Kaipeng Xie,Meng Zhu,Ningbin Dai,Yue Jiang,Xuejiang Guo,Mingxi Liu,Juncheng Dai,Linxiang Wu,Guangfu Jin,Hongxia Ma,Tao Jiang,Rong Yin,Yankai Xia,Li Liu,Shouyu Wang,Bin Shen,Ran Huo,Qianghu Wang,Lin Xu,Liuqing Yang,Xingxu Huang,Hongbing Shen,Jiahao Sha,Zhibin Hu +26 more
Explaining cancer type specific mutations with transcriptomic and epigenomic features in normal tissues.
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
Hiu Wing Cheung,Glenn S. Cowley,Barbara A. Weir,Jesse S. Boehm,Scott F. Rusin,Justine A. Scott,Alexandra East,Levi D. Ali,Patrick H. Lizotte,Terence C. Wong,Guozhi Jiang,Jessica Hsiao,Craig H. Mermel,Gad Getz,Jordi Barretina,Shuba Gopal,Pablo Tamayo,Joshua Gould,Aviad Tsherniak,Nicolas Stransky,Biao Luo,Yin Ren,Ronny Drapkin,Sangeeta N. Bhatia,Jill P. Mesirov,Levi A. Garraway,Matthew Meyerson,Eric S. Lander,David E. Root,William C. Hahn +29 more